THE COST-EFFECTIVENESS OF ENOXAPARIN IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN PATIENTS UNDERGOING MAJOR SURGERY IN EGYPT

被引：0
|
作者：
Farag, A. [1 ]
Moety, Abdel H. [1 ]
Hassan, L. [2 ]
Pathak, P. [3 ]
Lamotte, M. [4 ]
Levorsen, A. [5 ]
机构：
[1] Cairo Univ, Cairo, Egypt
[2] Alexandria Univ, Alexandria, Egypt
[3] QuintilesIMS, Dubai, U Arab Emirates
[4] IQVIA, Zaventem, Vbr, Belgium
[5] Sanofi, Global, France
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSU18
引用
收藏
页码：S895 / S895
页数：1
相关论文
共 50 条
  • [21] The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery
    Gordois, A
    Posnett, J
    Borris, L
    Bossuyt, P
    Jönsson, B
    Levy, E
    De Pouvourville, G
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (10) : 2167 - 2174
  • [22] A Canadian Study of the Cost-Effectiveness of Apixaban Compared With Enoxaparin for Post-Surgical Venous Thromboembolism Prevention
    Revankar, Nikhil
    Patterson, John
    Kadambi, Ananth
    Raymond, Vincent
    El-Hadi, Wissam
    [J]. POSTGRADUATE MEDICINE, 2013, 125 (04) : 141 - 153
  • [23] Enoxaparin Dosing and the Prevention of Venous Thromboembolism in Plastic Surgery Patients
    Swanson, Eric
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2017, 140 (06) : 835E - 836E
  • [24] Cost-effectiveness of dabigatran etexilate in Canada for the primary prevention of venous thromboembolism (VTE) in patients undergoing total knee replacement surgery (TKR)
    Bradley-Kennedy, C.
    Wolowacz, S. E.
    Roskell, N. S.
    Plumb, J. M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 786 - 786
  • [25] Cost-effectiveness of extended venous thromboembolism prophylaxis with fondaparinux in major orthopaedic surgery in Switzerland
    Sendi, P
    Leuppi, JD
    [J]. VALUE IN HEALTH, 2004, 7 (06) : 732 - 733
  • [26] Prevention of venous thromboembolism with enoxaparin in bariatirc surgery
    Woo, Hee Doo
    Kim, Yong Jin
    [J]. JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2013, 84 (05): : 298 - 303
  • [27] Cost-effectiveness of fondaparinux vs. enoxaparin as venous thromboembolism prophylaxis in Sweden
    Jonas Lundkvist
    David Bergqvist
    Bengt Jönsson
    [J]. The European Journal of Health Economics, formerly: HEPAC , 2003, 4 (4): : 254 - 262
  • [28] Transfusions, major bleeding, and prevention of venous thromboembolism with enoxaparin or fondaparinux in thoracic surgery
    Girard, Philippe
    Demaria, Joelle
    Lillo-Le Louet, Agnes
    Caliandro, Raffaele
    Le Guillou, Jean-Luc
    Crespin, Malvina
    de Sanctis, Alice
    Stern, Jean-Baptiste
    [J]. THROMBOSIS AND HAEMOSTASIS, 2011, 106 (06) : 1109 - 1116
  • [29] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, L.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A41 - A41
  • [30] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, E.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A40 - A40
12345